International
reported revenues were $7.1 billion, a decrease cipralex azithromycin and coffe of 1% compared with the year-ago quarter, and reflect operational growth of 5%, which was elocon and hair more
than offset by the unfavorable impact of online pharmacist foreign exchange of 6%. Reported revenues accounted chemist for 43% of the total compared. Reported revenues were $5.3 billion in fourth-quarter 2008, a decrease of 8% compared with the year-ago quarter.
NEW YORK-- --Pfizer Inc (NYSE. PFE - News) today reported financial results for
fourth-quarter and full-year 2008. This decrease was primarily attributable to augmentin the negative online pharmacies impact of the combinatie cymbalta en ginko biloba goed loss of U.S. In addition, foreign exchange unfavorably impacted reported revenues azithromycin by approximately
$380 million or levaquin online 3%, partially offset by drugstore the drug store solid performance of key products.
For fourth-quarter prescription online pharmacy percocet 2008, the Company
- recorded reported revenues of $12.3 billion, a decrease of 4% compared otc sleeping pills
antibiotic with the year-ago quarter. Zyrtec, Camptosar and Norvasc fourth-quarter 2008 international pharmacy revenues decreased by $515 million ($263 million, $144 million and $108 million, respectively), compared with prescription medication the year-ago quarter. Exclusivity for Zyrtec allopurinol gout in and for Camptosar in as aciclovir well as the loss of exclusivity prescription for azithromycin or doxycycline for Norvasc in Korea and Japan in and July amoxicillin and potassium clavulanate 2008, respectively. ($ in millions, except per share amounts) Fourth-Quarter Full-Year of salonpas external pain relief patch salonpa amoxycillin 2008 2007 Change 2008 2007 hyssop licorice genital herpes Change prescription drugs Reported Revenues $ 12,346 avelox antibiotic cost $ 12,870 tetracyclin (4%) $ 48,296 $ 48,418 -- Reported Net Income 266 2,724 citromax antibiotic (90%) chemist 8,104 8,144 -- Reported Diluted EPS 0.04 zithromax 0.40 (90%) 1.20 1.17 3% Adjusted Revenues(1) 12,311 12,795 (4%) 48,341 aldara rexall 48,209 -- Adjusted Income(1) 4,389 3,402 29% 16,366 15,113 8% Adjusted Diluted EPS(1) 0.65 0.50 30% 2.42 2.18 11% See end of text prior to tables for notes.